Rhinomed Limited


Rhinomed Limited ASX:RNO

Rhinomed Limited (ASX:RNO) is a Melbourne based technology firm with a focus on nasal, respiratory and breathing management technologies. Rhinomed is seeking to radically improve the way you breathe, sleep, maintain your health and take medication. The company is rapidly commercializing its platform and has brought two products to market that are now sold globally. For more information, go to www.rhinomed.global

TwitterFollow the Turbine on Twitter at @theturbinecom
Follow Mute Snoring on Twitter at @mutesnoring



Rhinomed Limited (ASX:RNO) Signs 12-Year Licensing Agreement with America's Largest Medical Cannabis Operator - Columbia Care LLC

🕔10/3/2018 8:30:39 AM 1031

Melbourne based nasal respiratory company Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) is pleased to advise investors it has signed a 12-year exclusive licensing agreement of its nasal platform technology with Columbia Care LLC, the largest and most experienced provider of cannabis-based products and services in the United States (U.S.).

Read Full Article

Rhinomed Limited (ASX:RNO) and US Based Columbia Care LLC to Develop Nasally Delivered Dose Controlled Cannabis Based Medicines

🕔6/21/2018 11:20:00 AM 2290

Melbourne based nasal respiratory company Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) is pleased to advise investors that it has signed a non-binding term sheet with Columbia Care LLC to license Rhinomed's nasal platform for the delivery of medical cannabis and cannabinoid compounds, analogues and derivatives.

Read Full Article

Rhinomed Ltd (ASX:RNO) Business Update - December Quarter

🕔1/30/2018 8:55:12 AM 3125

Respiratory technology company Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF) can report another strong quarter of growth. During the quarter the company shipped and invoiced $602k ($1.2m for the half year) worth of stock to retailers, consumers and distributors. This reflects the strength of the Company's growing global retail distribution base.

Read Full Article

Rhinomed Ltd (ASX:RNO) Completes AUD $3.6 Million Capital Raising

🕔11/29/2017 9:44:28 AM 2386

Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF) a leading sleep and nasal respiratory technology company has successfully undertaken an AUD$3.6 million placement to institutional and sophisticated private investors at $0.15 per share.

Read Full Article

Rhinomed Ltd (ASX:RNO) Investor Presentation October 2017

🕔10/5/2017 10:24:59 AM 2790

Rhinomed Ltd (ASX:RNO) (OTCMKTS:RHNMF) provides the Company's latest Investor Presentation.

Read Full Article

Rhinomed Ltd (ASX:RNO) Preliminary Final Report

🕔8/28/2017 6:45:01 PM 1505

The Directors of Rhinomed Limited ASX:RNO) provide the following Report in relation to the Group for the year ended 30 June 2017.

Read Full Article

Rhinomed Limited (ASX:RNO) Froome Wins 4th Tour De France Using Turbine

🕔7/25/2017 2:49:05 PM 3076

A yellow nose ring matches the yellow jersey. Chris Froome, having taken his 4th Tour de France title continues to support yellow - in the form of an innovative sports breathing device called Turbine(TM).

Read Full Article

Rhinomed Ltd (ASX:RNO) Major Expansion of Mute USA Retail Footprint

🕔7/17/2017 9:55:16 AM 3188

Rhinomed Limited (ASX:RNO) (OTCMKTS:RHNMF), is pleased to announce that it has been advised that its sleep and breathing technology Mute, has been added to the annual 'large set' planogram produced by the Hamacher Resource Group, Inc.

Read Full Article

Rhinomed Ltd (ASX:RNO) May 2017 Investor Update - Delivering End to End Sleep Category Solutions

🕔5/16/2017 9:59:50 AM 2900

Rhinomed Ltd (ASX:RNO) (OTCMKTS:RHNMF) are pleased to provide the Company's latest Investor Update for May 2017.

Read Full Article

Rhinomed Ltd (ASX:RNO) Amcal and Guardian Core Range Mute Australia Wide

🕔5/8/2017 10:11:03 AM 3555

Respiratory technology company Rhinomed (ASX:RNO) (OTCMKTS:RHNMF) is pleased to announce that it has been advised by Sigma Healthcare (ASX:SIG) that Mute sleep technology will form part of the 2017 core range for the Amcal and Guardian pharmacy brands.

Read Full Article


  • This Page Viewed: (Last 7 Days: 79) (Last 30 Days: 448) (Since Published: 24286) 

Markets ASX:RNO

Company Data

  • 97 Green St
    Vic 3121
  • Telephone
  • +61-3-8416-0900 
  • Fax
  • +61-3-8080-0796 
  • Principal Sector
  • Consumers 
  • Principal Industry
  • Medical Products 
  • Homepage
  • www.rhinomed.com.au
  • E:
  • mjohnson@rhinomed.com.au

Company Reports


Quarterly Report

Social Media